Key PointsTotal revenue increased 8% to $19 million in the third quarter.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Fortress Biotech: 3 Key Takeaways for Long-Term Investors
